Skip to main content

McSweeney Erin's Form 4 filing

UnitedHealth Group IncUNH · filed Apr 25, 2023

Accession no.
0001209191-23-025620
Filed
Apr 25, 2023
Trade date
Apr 21-25, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.69M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
McSweeney ErinCIK 0001645325Officer (EVP Chief People Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 21, 2023Common StockSSaleDisposed−1,008$484.58−$488,456.6410,359.41Direct
Apr 24, 2023Common StockSSaleDisposed−1,684$488.46F1−$822,566.648,675.41Direct
Apr 24, 2023Common StockMOption exerciseAcquired+6,000$302.20+$1,813,20014,675.41Direct
Apr 24, 2023Common StockFTax withholdingDisposed−4,621$486.60−$2,248,578.610,054.41Direct
Apr 25, 2023Common StockSSaleDisposed−761$494.80−$376,542.89,293.41Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 24, 2023Common StockMOption exerciseAcquired+6,000$0.00$09,248Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This transaction was executed in multiple trades ranging from approximately $487.35 to $489.80 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)